Brief: ReShape Lifesciences Q1 Net Income USD -2.193 Million
15/05/2024 21:05
May 15 (Reuters) - ReShape Lifesciences Q1 revenue USD 1.944 million. * Q1 operating income USD -2.21 million * Q1 pretax profit USD -2.179 million * Q1 operating expenses USD 3.375 million * Q1 gross profit USD 1.165 million
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity